The GSTA4 methylation in non-smoker IAs were much lower than that in the smoker controls and non-smoker controls ( p .05, Figure 3G)
They directly bind to the 3'-untranslated region (3'-UTR) of a targeted transporter gene to regulate its transcription, leading to abnormalities in drug influx and efflux [18]
4.) Binding mycotoxins from the system using either the medication cholestyramine or the natural product, charcoal, helps to get the excess toxins out of the body and prevent recirculation into the bloodstream
By increasing the activity of endogenous enzymes like Superoxide Dismutase (SOD) and reducing lipid peroxidation (MDA levels), GHK-Cu actively neutralizes reactive oxygen species (ROS)
Stop taking this medicine immediately and consult a physician, dentist, or pharmacist if any of the following occur
Specifically, we are interested in the following themes: Novel therapeutic target(s) for psoriatic disease Recently (last 5 years) approved therapies for psoriatic disease Biosimilars - role in psoriatic disease Safety profile of newer therapies Economic impact of newer therapies on health system Newer mode of drug-delivery system in psoriatic disease Therapeutic prospect of small molecules in psoriatic disease Therapeutic guidelines to combine newer therapies with conventional therapy in psoriatic disease Plant derived compounds in psoriatic disease Pathophysiology and therapies in the future of psoriasis and psoriatic arthritis treatment Psoriasis and psoriatic arthritis are complex autoimmune diseases affecting ~2-3% of world population